申请人:Schering Aktiengesellschaft
公开号:US04011314A1
公开(公告)日:1977-03-08
7-Hydroxyestradiols of the formula ##STR1## wherein R.sub.1 is hydrogen, acyl, alkyl, cycloalkyl, an oxygenated saturated heterocyclic group or hydrocarbylsulfonyl; R.sub.2 and R.sub.3 each are hydrogen, acyl, oxygenated saturated heterocyclic group or R.sub.2 is hydrocarbylsulfonyl and R.sub.4 is alkyl, alkenyl, chlorinated alkenyl, alkynyl or chlorinated alkynyl, are useful for treating estrogen deficiency symptoms.
公式为##STR1##的7-羟基雌二醇,其中R.sub.1是氢、酰基、烷基、环烷基、含氧饱和杂环基团或烃基磺酰基;R.sub.2和R.sub.3分别是氢、酰基、含氧饱和杂环基团或R.sub.2是烃基磺酰基,R.sub.4是烷基、烯基、氯代烯基、炔基或氯代炔基,可用于治疗雌激素缺乏症状。